ClinicalTrials.Veeva

Menu

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

Columbia University logo

Columbia University

Status

Terminated

Conditions

Stroke

Treatments

Behavioral: Aphasia therapy
Device: Sham tDCS
Device: Anodal tDCS

Study type

Interventional

Funder types

Other

Identifiers

NCT02461355
AAAO1700

Details and patient eligibility

About

This is a randomized, crossover design trial that will compare how anodal transcranial direct current stimulation (tDCS) versus sham tDCS administered during multiple sessions of scripting therapy affects the acquisition and retention of trained scripts.

Enrollment

2 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age over 21 years
  2. Ischemic left hemispheric stroke verified by imaging (CT or MRI) greater than 6 months ago
  3. Residual non-fluent or anomic aphasia, with Western Aphasia Battery-Revised Aphasia Quotient score <60
  4. Fluent English speaker prior to stroke
  5. Right-handed prior to stroke
  6. Ability to give informed consent and understand the tasks involved.

Exclusion criteria

  1. History of recurrent stroke, either ischemic or hemorrhagic, in the left middle cerebral artery territory
  2. Imaging unavailable
  3. Large middle cerebral artery infarct involving entire inferior division (temporo-parietal) territory
  4. History of dementia prior to the stroke
  5. History of seizure, prior electroconvulsive therapy, deep brain stimulators, or brain surgery
  6. Social and/or personal circumstances that interfere with ability to return for therapy and assessment sessions.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

2 participants in 2 patient groups

Anodal tDCS
Experimental group
Description:
Anodal tDCS over the left posterior language areas during aphasia therapy for 8 one-hour sessions
Treatment:
Device: Anodal tDCS
Behavioral: Aphasia therapy
Sham tDCS
Sham Comparator group
Description:
Sham tDCS over the left posterior language areas during aphasia therapy for 8 one-hour sessions
Treatment:
Device: Sham tDCS
Behavioral: Aphasia therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems